Table 1 Baseline characteristics of the participants.
Variable | Screened participants (n = 203) | Participants included in baseline assessment of dose‒response trial (n = 108) |
|---|---|---|
Demographic and anthropometry1 | ||
Age (years) | 22.80 ± 4.60 | 20.50 ± 1.10 |
Height (cm) | 157.40 ± 5.60 | 158.38 ± 5.34 |
Weight (kg) | 55.52 ± 8.63 | 53.27 ± 5.73 |
BMI (kg/m2) | 22.42 ± 3.40 | 21.22 ± 1.91 |
BMI (WHO classification)2 | ||
Underweight, n (%) | 7 (3.45) | 0 (0.00) |
Normal, n (%) | 159 (78.30) | 108 (100.00) |
Overweight, n (%) | 37 (18.23) | 0 (0.00) |
Obese, n (%) | 0 (0.00) | 0 (0.00) |
Occupation | ||
Staff (doctors, nurses, research) | 58 (28.57) | 3 (2.78) |
Students (nursing, doctoral, other) | 145 (71.43) | 105 (97.22) |
Vitamin D (25(OH)D) Status (ng/mL) | ||
Deficient (< 12 ng/mL), n (%) | 131 (64.53) | 83 (76.85) |
Insufficient (12–20 ng/mL), n (%) | 41 (20.20) | 25 (23.15) |
Vitamin D Total (25(OH)D, ng/mL) | 12.99 ± 8.82 | 9.83 ± 3.44 |